Učitavanje...
Investigating investment in biopharmaceutical R&D
Recent studies have highlighted a reduction in projected financial returns associated with biopharmaceutical R&D, owing to decreased productivity, increases in costs and flattening revenue per new drug, prompting calls for dramatic revisions to R&D models. On the basis of previous financial...
Spremljeno u:
| Izdano u: | Nat Rev Drug Discov |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5100010/ https://ncbi.nlm.nih.gov/pubmed/27616295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd.2016.104 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|